# A Study to Assess the Effects of Cyclosporine on the Pharmacokinetics and Safety of Canagliflozin (JNJ-28431754) in Healthy Volunteers

> **NCT01718652** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Canagliflozin (JNJ-28431754)
- **DRUG:** Cyclosporine

## Key facts

- **NCT ID:** NCT01718652
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718652, "A Study to Assess the Effects of Cyclosporine on the Pharmacokinetics and Safety of Canagliflozin (JNJ-28431754) in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01718652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*